Olinding, Lolita M.
HRN: 05-06-48 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/10/2022
CLINDAMYCIN 300MG (CAP)
06/10/2022
06/15/2022
ORAL
300 Mg
Q6
Infected Stump, Left
Waiting Final Action
Indication: Empirical De-escalation Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes